MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Focused Ultrasound Thalamotomy for Tremor-Dominant Parkinson Disease – Ablation Volume and Dentatorubrothalamic Tract Overlap Does Not Predict Outcome

    J. Peters, J. Maamary, K. Kyle, I. Osborne, N. Olsen, L. Jones, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

    Objective: To report the long-term outcomes in Tremor-Dominant Parkinson Disease (TDPD) after a unilateral Focused Ultrasound (uni-FUS) thalamotomy and explore factors that may predict the…
  • 2024 International Congress

    Unilateral Deep Brain Stimulation in Parkinson’s Disease: Long-term Efficacy and Bilateral Symptom Progression

    S. Akkus, H. Park, W. Saengphatrachai, J. Jimenez-Shahed, B. Kopell (New York, USA)

    Objective: To investigate the long-term efficacy of unilateral deep brain stimulation and the progression of motor symptoms on the untreated side in Parkinson's disease (PD)…
  • 2024 International Congress

    Is the sebum RNA transcriptome analysis technique capable of non-invasively diagnosing Parkinson’s disease?

    T. Iseki, Y. Ueda, T. Kuwano, T. Inoue, S. Saiki, N. Hattori (Bunkyo-ku, Japan)

    Objective: Our goal was to explore the potential of skin-surface lipid RNA transcriptome analysis as a diagnostic tool for Parkinson's disease. Background: Seborrheic dermatitis is…
  • 2024 International Congress

    Reliability of Digital Measures in Parkinson’s Disease and Their Implications for Sample Size Calculations

    J. Lavine, A. Scotina, S. Haney, E. Izmailova, L. Omberg (New York, USA)

    Objective: Assess the reliability and measurement error of measures derived from digital health technologies (DHTs) in Parkinson’s Disease (PD) patients and estimate sample size for…
  • 2024 International Congress

    Empower-PD: “An Exploratory Investigation of Accelerometer Data on Parkinson’s Patients’ Motor Symptoms and the Correlation with Quality of Life.”

    M. Hansen, B. Sørensen, T. Thomsen, N. Karottki (Copenhagen, Denmark)

    Objective: To describe weekly changes in bradykinesia-score (BKS) measured on objective wearable data and assess the correlation between these changes and Quality of Life (QoL)…
  • 2024 International Congress

    Evaluating the Effect of Myofascial Release on Parkinson’s Related Tremor

    S. Phelps (Cardiff, United Kingdom)

    Objective: Parkinson’s disease (PD) is the second-fastest neurological disorders in the world. Although there is no cure, medicines, surgical treatment, and other therapies can treat…
  • 2024 International Congress

    The Genetic Landscape of Parkinson’s Disease in an Italian Cohort and the Need for a Standardized Approach

    AT. Cimmino, P. Sanginario, F. Musso, D. Genovese, A. de Biase, M. Petracca, F. Bove, C. Piano, FD. Tiziano, AR. Bentivoglio, P. Calabresi, G. Di Lazzaro (Rome, Italy)

    Objective: Our study aimed to identify the genetic determinants and their prevalence in an Italian cohort of Parkinson’s disease (PD) patients. Background: Advances in genetics…
  • 2024 International Congress

    Utilizing a global network to study environmental factors relating to Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)

    K. Atterling Brolin, L. Jones, B. Fiske, S. Jasaityte, H. Morris, A. Noyce (Lund, Sweden)

    Objective: To identify and collect data on non-genetic variables from individuals with and without Parkinson’s disease (PD) in the Global Parkinson’s Genetics Program (GP2, http://gp2.org/).…
  • 2024 International Congress

    Artificial intelligence: a potential predictor of GBA1-mutated genotype in Parkinson’s Disease patients?

    G. Di Rauso, A. Ghibellini, S. Grisanti, F. Cavallieri, V. Fioravanti, E. Monfrini, G. Toschi, G. Portaro, J. Rossi, R. Sabadini, L. Gherardini, C. Lucchi, G. Biagini, L. Bononi, M. Gabbrielli, A. Di Fonzo, F. Valzania (Reggio Emilia, Italy)

    Objective: To assess whether artificial intelligence could predict GBA1-mutated genotype in Parkinson’s Disease (GBA1-PD) patients according to the different impact of significant clinical features. Background:…
  • 2024 International Congress

    Frequency of Variants of Uncertain Significance in a Cohort of Early-onset Parkinson’s Disease Patients

    A. Zare Dehnavi, C. Piat, N. Niu, O. Ross, A. de Menezes, P. Gaia, R. Savica (Rochester, USA)

    Objective: Aim of the study is to report the frequency of variants of uncertain significance (VUS) in a cohort of patients with early-onset Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley